blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1



Friday, 25 February 2011

SCIENTOLOGY & BOB FIDDAMAN - Workin' is for fools... dedicated to Bob Fiddaman - AC/DC June 2001







I never worked in no factory
I never tried much to
But I'm hardly a man, don't you understand
And unemployment = booze







Rover Inc told me to go fly a kite
So the dole is what I abuse
Hit 'em up, with a big load of shite
Socialism's better than cooze...





'Cause workin' is for fools...
Workin' is for fools...
Ain't nothin' for me to do...
I prefer to jerk my tool...
'Cause workin' is for fools...



http://groups.google.co.uk/group/alt.rock-n-roll.acdc/browse_thread/thread/5c8592af926acc45/fa0c1f1592e040e9?hl=en&ie=UTF-8&q=bob%2Bfiddaman

Thursday, 24 February 2011

GSK says 300 person UK lawsuit on Seroxat is without merit - 2008

GSK says UK lawsuit on Seroxat is without merit


UK News / World News
January 10, 2008



Kevin Grogan







GlaxoSmithKline has again spoken out in defence of Seroxat as reports re-emerged concerning lawsuits being filed in the UK against the firm and its blockbuster antidepressant.



The news agency Bloomberg reported that GSK is being sued for around £15.7 million by over 300 patients who claim the company was negligent or committed a statutory breach of duty dating back to 1997 regarding Seroxat (paroxetine), which is sold as Paxil in the USA. Mark Harvey of Wales-based law firm Hugh James Solicitors filed the suit at the London High Court on December 19 on behalf of the plaintiffs who are alleging that they suffered withdrawal symptoms when stopping treatment of the drug.



The law firm has been speaking to other media outlets over the past few months about the suit but the reality is that the case is not likely to be heard for several years.



A GSK spokesman told PharmaTimes World News that the filing did not represent any call for alarm and the firm does not feel it has any case to answer. He said that "we believe there is no merit in this litigation. Seroxat has benefited millions of people worldwide who have suffered from depression”, adding that “this is a routine step in the litigation which we are continuing to defend."



A class action lawsuit has already been filed against GSK in the USA over paroxetine, which claims that the firm withheld important information on the drug's effect on children. GSK has repeatedly rejected suggestions that it has behaved improperly in terms of covering up unfavourable data.







Links

www.gsk.com

http://www.pharmatimes.com/Article/08-01-10/GSK_says_UK_lawsuit_on_Seroxat_is_without_merit.aspx



Scientology - Rehabilitation Project Force

The Rehabilitation Project Force, or RPF, is a controversial program set up by the Church of Scientology Sea Organization, intended to rehabilitate members of the Sea Organization (not everyday parishioners) who have not lived up to the Church expectations or have violated certain policies. As part of this program, and in addition to the application of Scientology procedures, members do manual labor tasks around Sea Org bases. There have been some reports of overwork and mistreatment at RPF facilities[1], and the program can take years to complete.[2][3][4]




Contents [hide]

1 Development

2 Controversy

3 Castile Canyon School

4 Motto

5 See also

6 References

7 External links



Paxil a short "half life" drug - but Efexor Effexor is much shorter - The Evidence is clear








http://www.clinical-depression.co.uk/half_life.htm   
Seroxat/paroxetine half life = 21 to 26 hours,
Efexor/venlafaxine half life = 5 (5 to 11) hours



Venlafaxine in doses up to 150mg is an SSRI. Over 150 mg it also inhibitsnoradrenaline reuptake. Duloxetine is a potent serotonin reuptake inhibitor butnot selective to the serotonin system

You can access this file at the URL:http://groups.yahoo.com/group/SSRI-Crusaders/files/Healy_Withdrawal_june_09.pdf





Complaint Allegations:

http://bobfiddaman.blogspot.com/2011/02/paxil-withdrawal-reactions-class-action.html
1) The lawsuit further alleges that Paxil is a short "half life" drug which means it leaves
the body at a relatively fast rate. GSK uses this feature to distinguish it from its
competitors alleging that, as a result, it has a shorter
duration of adverse events, decreased drug accumulation over time, better management
of sexual dysfunction, and reduction of time to establish steady state drug regimen. The
great disadvantage of a short half life
substance, however, is that it is more addictive, has a greater tendency to induce
physical and psychological dependency, and causes withdrawal reactions. While these
characteristics of "half life" substances have been well known among Defendant and
psychopharmacologists, such information is not generally known by general practice
physicians or even psychiatrists.

Paxil Withdrawal Reactions Class Action 2001- Fact sheet from Robin McCall of Baum Hedlund

Fact Sheet - Paxil Withdrawal Reactions Class Action


Posted on: Saturday, August 25, 2001 at 16:40:33 (EDT)

http://www.stuartshipko.com/FAQ//paxilclass.html


Paxil is being touted as the "nonaddicting" treatment for panic disorder with a "more favorable side effect profile". It may be that it is highly addicting and loaded with side effects.



Fact Sheet - Paxil Withdrawal Reactions Class Action



The 35 plaintiffs named in the lawsuit are from AZ, CA, CO, FL, IN,KY, LA, MN, MO, NC,

NE, NJ, NV, OK, OR, TN, TX, UT, WI, and WY. Several of them are willing to talk to the

media. If you wish to speak with a victim please call
 Robin McCall listed in the contact information.



Plaintiffs' lawyers have argued for years that antidepressants, such as Prozac, Paxil and

Zoloft, can induce some to experience adverse reactions which can result in suicide and

violence.



This summer, the New South Wales Supreme Court ruled that had it not been for David

John Hawkins' ingestion of Zoloft, he would not have strangled his wife of 50 years.



Last month GlaxoSmithKline was ordered by a federal jury in Cheyenne,Wyoming to pay

$6.4 million to relatives of Donald Schell, age 60, who had been taking Paxil for just 48

hours when he experienced hallucinations and shot and killed his wife, his daughter, his

granddaughter and then himself.



In the Spring of 2000, a Connecticut man, Christopher DeAngelo, was acquitted of armed

bank robbery based on his suffering from a manic reaction to Prozac at the time of his

crime.



This Paxil Class Action is the first of its kind against an SSRI maker, i.e.,in connection

with the drug's withdrawal reactions.



The first SSRI to reach the U.S. market was Prozac. The second was Zoloft, then came

Paxil. Collectively, the SSRI's (selective serotonin reuptake inhibitors) have been

approved for marketing in the U.S. for such conditions as depression, obsessive

compulsive disorder, post traumatic stress syndrome, and "premenstrual dysphoric

disorder."



SSRI's effect the brain's ability to reabsorb serotonin, a neurotransmitter in the brain,

which is supposed to affect mood, sleep and appetite.



Complaint allegations re victims:



An exemplar of the plaintiffs in this Class Action are briefly described below as well as

what they have suffered, according to the complaint:



Plaintiff #1 of North Hollywood, California was originally prescribed Paxil in September

1999, by her OB GYN. In the year 2000, she attempted to discontinue use of the drug

with her doctor's approval. Upon initial discontinuation of dosage and continuing

thereafter until February 2001, she experienced severe withdrawal reactions including,

but not limited to, restlessness and pain which severely impaired her ability to perform

activities of daily living. She did not know she was experiencing Paxil withdrawal.



Plaintiff #2 of Hollywood, California is a website designer who was prescribed Paxil by her

doctor for "panic attacks." Soon after taking the drug, her ability to eat and sleep were

severely impaired, and she was "nerved out all the time." When she decided to stop

taking the drug, her physician instructed her to lower her dose to 10mg. After about a

month and shortly after her last pill was consumed, she experienced frightening physical

sensations, including the sensation of being shocked with electrical charges,

uncontrollable shaking and unwanted intrusive thoughts. She did not know this was

caused by Paxil.



Plaintiff #3 of San Diego, California, first took Paxil in July 2000 which was prescribed by

her internist and allergist. When she tried to discontinue use of Paxil, she experienced

unwanted sensations of sharp,

intermittent stabbing pain in her head, severe headaches, dizziness,nausea, weakness in

her body and legs, shakiness, and severely impaired ability to perform mental functions.

As time passed, the reactions got worse and she became bedridden. She thought she

was losing her mind and that she had a brain tumor. She was hospitalized and had a CT

scan. It was not until later that she discovered her reactions were caused by

Paxil withdrawal. As of April 2001, she continues to suffer the injurious effects of Paxil

withdrawal.



Plaintiff #4 of El Cajon was prescribed Paxil in June 2000. Because she quickly gained 25

pounds on the drug, she was prescribed to discontinue the use of Paxil. She was

prescribed a tapering regime which was extremely painful and she suffered painful

reactions. At the time, she did not know these reactions were due to Paxil. From October

2000 to January 2001, she kept taking Paxil to combat her withdrawal reactions.

As of February 2001, she was still suffering shocks from Paxil withdrawal.



Plaintiff #5 of San Diego, California a Texas Tech University graduate, an ex Marine, and

a veteran of Desert Storm. In the spring of 1995, he was first prescribed Paxil. Initially

his physician told him that Paxil's side effects were mild, and specifically that there were

no problems stopping the drug if it was done gradually over a few weeks. After 5 years

on the drug, while discontinuing use of Paxil, he suffered debilitating physical and

psychological reactions, and became at times disabled. Unbeknownst to him, the

reactions were Paxil withdrawal. In August 2000, still suffering as he tried to reduce his

Paxil usage, he saw the television program "20/20" regarding Paxil withdrawal. It was at

that time he became determined to

wean himself off of Paxil once and for all. He continues to suffer Paxil withdrawal until the

end of the year 2000.



None of the named plaintiffs were ever informed before starting Paxil that it was

addictive, induced dependency, or created withdrawal problems when dosage was

reduced or terminated.



The claims of Plaintiffs are typical of the class and of other Paxil withdrawal victims. Each

of the Plaintiffs and class members were

uninformed of the hazards in reducing or terminating their Paxil dosage.

Each of them did, in fact, reduce or terminate their daily Paxil intake. Within one or two

days thereafter, severe withdrawal reactions appeared.



Complaint Allegations:



1) The lawsuit further alleges that Paxil is a short "half life" drug which means it leaves

the body at a relatively fast rate. GSK uses this feature to distinguish it from its

competitors alleging that, as a result, it has a shorter

duration of adverse events, decreased drug accumulation over time, better management

of sexual dysfunction, and reduction of time to establish steady state drug regimen. The

great disadvantage of a short half life

substance, however, is that it is more addictive, has a greater tendency to induce

physical and psychological dependency, and causes withdrawal reactions. While these

characteristics of "half life" substances have been well known among Defendant and

psychopharmacologists, such information is not generally known by general practice

physicians or even psychiatrists.



2) The habit-forming nature of Paxil has not been fully divulged to physicians in the

United States, hence neither physician nor patient has had sufficient information to

weigh the benefits/risks associated with Paxil. Serious habit forming characteristics

affect the patient, and he/she is

unable to wean himself/herself off of the drug after therapeutic use is no longer needed.

Physical and psychological dependency on Paxil is the result. When withdrawal problems

arise, the patient often feels entrapped, in despair, and desolate.



3) From 1992 to the present, patients attempting to taper down or discontinue use of

Paxil have suffered withdrawal reactions and dependency/withdrawal syndrome, as noted

above. In addition to the physical reactions mentioned above, patients can also

experience

psychiatric reactions such as anxiety, agitation, lability of mood, nervousness,

hypersexuality, crying spells, irritability and despair. The result of these combined

reactions is that many patients continue to take Paxil because they are unable to endure

the withdrawal reactions.



4) "Relapse" is not "withdrawal." Relapse occurs when a patient who has improved his/her

depressive state, then reverts back to a more seriously depressed state. Symptoms

exhibited during relapse are frequently

comparable to reactions exhibited during withdrawal. As indicated elsewhere in this

complaint, it is alleged on information and belief that GSK, over the years, categorized

numerous patients' withdrawal reactions as relapse symptoms. GSK did this in order to

gain FDA approval for Paxil and avoid revealing the drug's withdrawal problems.



5) After representing to the FDA that Paxil had been systematically tested for withdrawal

and that the tests were successful, Paxil was approved for marketing in the United

States. However, at that time and prior thereto, GSK knew of the withdrawal problems

with Paxil (particularly from its clinical trials, including those held in Yugoslavia). Contrary

to obtaining its marketing approval from the FDA based on its "systematic testing," GSK's

label for Paxil stated:

DRUG ABUSE AND DEPENDENCE. Physical and Psychologic Dependence: "Paxil has not

been systematically studied in animals or human for its potential for abuse, tolerance, or

physical dependence. While the clinical trials did not reveal any tendency for any drug

seeking behavior, these observations were not systematic and it is not possible to

predict on the basis of this limited experience the extent to which a . . . (central nervous

system) . . . active drug will be misused, diverted and/or abused once

marketed. Consequently, patients should be evaluated carefully for history of drug abuse,

and such patients should be observed closely for signs of Paxil misuse or abuse (e.g.,

development of tolerance, incrementations of dose, drug seeking behavior).



The above prescribing information and labeling is false and misleading on its face.



6) Evidence of GSK's knowledge of the withdrawal reactions its drug causes can also be

found in a report to Dr. Martin Brecher of the FDA which disclosed subjective reporting

gathered from patients by cinical investigators who told GSK management that Paxil was

dangerously addictive. A group of 108 patients ending their participation in a trial told

GSK that Paxil had caused them to suffer "withdrawal" reactions ("Group

of 108 Complaining Patients' Study"). Out of the 1293 patients in that trial, the 108

complaining patients constituted 8.3% of the participants. GSK improperly reclassified

these patients' withdrawal reactions as

"relapse" symptoms.



Complaint Allegation Claims:



First Claim for Relief for Fraud and Deceit

Since December 29, 1992, when Paxil was first approved by the FDA, GSK has defrauded

the medical profession in general, Plaintiffs' and their physicians in particular, and the

Paxil patient population in general, in that

it, among other acts:

(a) Knowingly mischaracterized and miscoded withdrawal syndrome occurring during the

clinical trials so as to reduce the number of recorded occurrences of withdrawal

reactions;

(b) Failed to inform the medical community that a significant number of individuals taking

Paxil during foreign clinical trials experienced withdrawal reactions and

dependency/withdrawal syndrome;

(c) Knowingly misrepresented and continues to misrepresent that its clinical trials and

investigations adequately tested for dependency withdrawal syndrome;

(d) Knowingly claimed that Paxil's withdrawal problems were a relapse, when in fact they

were not;

(e) Actively deceived Plaintiffs and class members by representations in written labeling

and oral communications suggesting that Paxil is not addictive, that it does not cause

physical or psychologic dependency, and

that it would not cause withdrawal reactions if dosage were reduced or terminated.

(f) Answering the question: "Is Paxil addictive?" with the response: "Paxil has been

studied both in short- and long-term use and is not associated with dependence or

addiction."

(g) Implementing false and misleading techniques to hide the linkage between

dependency/withdrawal syndrome on one hand, and Paxil on the other. After censoring

the word "withdrawal" from company files and

instructing its agents similarly, defendant GSK, began to dilute the medical vocabulary by

using misleading medical terms to substitute for withdrawal such as "discontinuation

syndrome."

(h) Over-promoting Paxil in order to increase its sale at the expense of revealing the

truth about the addictive/dependency nature of Paxil.

(i) Fraudulently conveyed to all health care providers in the U.S. that Paxil's side effects

were only "mild," when in fact GSK knew many of the drug's withdrawal side effects were

severe.

(j) Fraudulently conveyed to all health care providers in the U.S. that a British study

involving 13,741 patients illustrated that all of the SSRI's exhibited a similar rate of

withdrawal, when in fact GSK knew that study

illustrated Paxil to have the highest rate of withdrawal among SSRI's as recorded and

reported by the authors.

1. As a result of GSK's fraudulent acts and omissions as set forth herein, GSK has

deceived the medical community, including Plaintiffs' physicians, into believing Paxil does

not have the addictive qualities and does not cause dependency/withdrawal syndrome

which defendant GSK knows it in fact does.

2. When said representations were made by defendant GSK, it knew those

representations to be false, or in the alternative, willfully and wantonly and recklessly

disregarded whether the representations were true. These representations were made by

GSK, with the intent of defrauding and deceiving the public in general and the medical

community and to induce the medical community to recommend, prescribe, and dispense

Paxil and for the public to take it.

3. At the time the aforesaid representations were made by the defendant GSK, and at

the time that Plaintiffs ingested Paxil, both Plaintiffs and their prescribing physicians were

unaware of the falsity of said representations and reasonably relied on GSK's assertions,

promulgated through its

aggressive sales force to Plaintiffs' physicians as set forth herein, that the

drug was safe. In reliance upon said representations, Plaintiffs' physicians

did prescribe Paxil and Plaintiffs were induced to and did take Paxil. Had

Plaintiffs known of the actual dangers of Paxil, through their physicians or otherwise,

they would not have ingested Paxil.

4. GSK's motive of deliberately failing to advise physicians and the public of the adverse

effects that can lead to withdrawal problems (and that it knew a percentage of users of

the drug inevitably would experience) was for financial gain and its fear that, if properly

labeled, GSK would lose its share of the SSRI market through the efforts of competing

manufacturers who would adversely compare Paxil's half-life to their own. GSK's goal, at

the expense of those who took its antidepressant, was for Paxil to

become the dominant SSRI on the market.

5. At all times relevant herein, the conduct of defendant GSK, as set forth herein above,

was malicious, fraudulent and oppressive toward Plaintiffs and the public generally. GSK

conducted itself in a willful, wanton and

reckless manner as set forth herein above. Despite its specific knowledge as set forth

above, defendant GSK deliberately recommended, manufactured, produced, marketed,

sold, distributed, merchandized,

packaged, promoted and advertised the dangerous and defective drug Paxil. All of the

foregoing constitute an utter, wanton and conscious disregard of the rights and safety of

a large segment of the public, and by

reason thereof, defendant GSK, is guilty of reckless, willful and wanton acts and

omissions which evidence a total and conscious disregard for the safety of Plaintiffs and

class members.

6. As a proximate cause of defendant GSK's fraudulent and deceitful conduct and

representations and due to Paxil's addictive qualities, inducement of physical and

psychological dependency, and inducement of

dependency/withdrawal syndrome, all Plaintiffs and class members unexpectedly suffered

prolonged physical and mental anguish, harm, and suffering and have sustained damages

and other losses in an amount to be proven at trial.



Second Claim for Relief for Negligence

7. GSK owed Plaintiffs and class members a standard of care to ensure that they and

their physicians were adequately warned of Paxil's addictive qualities and

dependency/withdrawal characteristics before any were prescribed the drug. GSK

violated that standard of care through active

misrepresentations and failure to warn when it was GSK's duty to do so.



See complaint for more.



Third Claim for Relief for Strict Liability per § 402 Restatement (Torts)

8. At all times herein mentioned, defendants knew or should have known that Paxil was

and is addictive and causes withdrawal syndrome.

9. At all times hereinafter mentioned, neither members of the general medical community

nor members of the general public knew of the withdrawal dangers existing with respect

to the administration of Paxil.

10. Paxil was used by Plaintiffs and class members in the manner and amounts in which

the defendants intended it to be used.

11. At all times material hereto, in the United States, Paxil was not properly labeled by

defendants; in fact it was mislabeled and was not accompanied by proper warnings that

Paxil can cause withdrawal reactions and dependency/withdrawal syndrome.

12. Defendants promoted and maintained Paxil on the market both to physicians and

directly to patients/consumers with the knowledge of

Paxil's unreasonable risk to the public in general, and specifically to Plaintiffs and class

members.

13. Paxil, as used by Plaintiffs and class members, was defective and unreasonably

dangerous when sold by defendants, and defendants are strictly liable for the injuries

arising from its manufacture and Plaintiffs and class members' use.

14. As a direct and proximate result of the foregoing, Plaintiffs and class members

sustained damages and other losses according to proof.

Fourth Claim for Relief for Breach of Express Warranty - see complaint for information.



Fifth Claim for Relief for Breach of Implied Warranty - see complaint for information.

Paxil withdrawal class action 2001 comprised of only 35 people

LOS ANGELES (CNN) -- Thirty-five people who say they suffered from "severe withdrawal reactions" after taking the anti-depressant Paxil filed a class-action complaint against the drug's maker Friday in California Superior Court.




The complaint against pharmaceutical giant GlaxoSmithKline, which produces Paxil, alleges that the drug "is more addictive" and "has a greater tendency to induce physical and physiological dependency" than other anti-depressants.



Paxil, which was introduced to the U.S. market in December of 1992, is one of several anti-depressants classified as a selective seratonin reuptake inhibitor, or an S.S.R.I. drug. Other well known S.S.R.I. drugs are Prozac, which is manufactured by Eli Lilly; and Zoloft, made by Pfizer.



A section of the complaint charges that "GlaxoSmithKline has known for years the distinct characteristics of Paxil which make it prone to cause withdrawal reactions when discontinued."



The lawsuit was filed by Karen Barth in association with Mary Schiavo of Baum, Hedlund, Aristei, Guilford & Schiavo. The plaintiffs are seeking unspecified damages along with attorney's fees.



A U.S.-based spokeswoman for GSK, which has its headquarters in London, said the company does not have a statement at this time.



August 25, 2001

http://edition.cnn.com/2001/HEALTH/08/25/paxil.suit/

Wednesday, 23 February 2011

Paxil Heart Defect Warning Lawsuit torpedoed - failure to warn does not mean proximate cause


Pennsylvania Judge: Dead Doctor Torpedoes Paxil Heart Defect Warning Lawsuit






LexisNexis® Mealey's™ Emerging Drugs & Devices Legal News

PHILADELPHIA - A Pennsylvania judge on Jan. 12 issued an opinion denying reconsideration of summary judgment to GlaxoSmithKline PLC (GSK) in a Paxil heart defect case because without the testimony of the deceased prescribing physician, the plaintiff was unable to prove that a better warning would have changed his decision to prescribe the drug (Anna Carolina Blyth, et al. v. GlaxoSmithKline LLC, No. 070902205, Pa. Comm. Pls., Philadelphia Co.; See 12/16/10, Page 21). Full story on lexis.com

Tuesday, 22 February 2011

Suicide Group Launched In Auckland - founded by Scientology / CCHR

Steve Green, Director of the Citizens Commission on Human Rights (CCHR) also spoke of his support as a founding member of CASPER,

Suicide Group Launched In Auckland


http://www.voxy.co.nz/national/suicide-group-launched-auckland/5/60064

A new group has been formed by people concerned with the huge numbers of people dying in New Zealand from suicide. CASPER or Community Action on Suicide Prevention, Education & Research was launched at a function on the North Shore last night.




North Shore woman Maria Bradshaw who lost her 17 year old son Toran presented up to date damning research to a large group of people including bereaved family members, health professionals, youth workers, young people, businessmen and women, NGOs and counsellors. Many were visibly shocked by information from the Child and Youth Mortality Review Committee that 10% of deaths of 10 year olds in New Zealand are from suicide, that Maori and Pacific youth account for almost 50% of youth suicides and that suicide amongst young women show an upward trend.



With around 10 people committing suicide a week in New Zealand, a call was made for families and communities to be provided with the information on suicide they need to keep their members safe. The information provided by SPINZ and the Ministry of Health that suicide rates are falling and that current prevention activities are effective were strongly challenged with data showing the figures these organisations produce and their analysis are inaccurate and misleading. Their latest report revealed that 483 people had committed suicide in 2007 when the recently released figures from the Chief Coroner showed that the correct figure was 541, a huge increase on the year before.



Mental health is often touted as the solution, however it was disclosed psychiatric intervention and treatments can worsen the risks of suicide to the point of double.



A 2004 study published in the Australian and New Zealand Journal of Psychiatry showed that the introduction of mental health initiatives rather than preventing suicide, actually increased suicide. This was a large study reviewing suicide prevention strategies of 100 countries.



Steve Green, Director of the Citizens Commission on Human Rights (CCHR) also spoke of his support as a founding member of CASPER, encouraging people to find out the facts and raise awareness of these issues. "People need practical help not psychotropic drugs with their horrendous side effects; it's time a thorough inquiry is conducted into suicide, its causes, prevention and mental health failings must be a part of this," Mr Green said.




CASPER aims to achieve a voice for families bereaved by suicide and to ensure they are accorded similar rights of families who were victims of crime.



What CASPER Believe:



Knowledge is power



Suicide is a social, not medical, issue.



Empowered, well informed families and communities are the key to suicide prevention



Suicide flourishes in silence.



Current suicide prevention strategies do not, and can not, work.



What CASPER does:



Gather and analyse national and international information on suicide and its prevention.



Put the information into a format able to be shared with those who can make a difference - families and the community.



Lobby for changes to legislation, policy and practice.



Support families seeking truth, justice and accountability

http://www.voxy.co.nz/national/suicide-group-launched-auckland/5/60064

New Zealand - Concerns raised over group's scientology link - Toran Henry

A new lobby group for families affected by suicide has sparked concerns over links with the Church of Scientology.


http://www.stuff.co.nz/national/health/4062089/Concerns-raised-over-groups-scientology-link

Casper (Community Action on Suicide Prevention, Education & Research) was formed by two mothers who lost their children to suicide.



However, Green MP Kevin Hague said the Citizens Commission for Human Rights (CCHR) was closely associated with Casper, and was established as an arm of the Church of Scientology.



Maria Bradshaw, mother of suicide victim Toran Henry, 17, said the new group would provide a voice for families affected by suicide, and lobby for legislative and policy changes.Families should have the same rights and support as victims of crime during coroner's inquests, she said.



"We have the information and support we need to keep our children safe from poisoning, drowning and drink-driving. We deserve to have the same information about an issue that causes 10 deaths a week in New Zealand."



Bradshaw said the new group hoped to meet with Prime Minister John Key to present its ideas.



"The Government needs to accept that what it is doing is not working, and to implement radical change in its approach to suicide prevention and the support of the families it affects," she said.



Bradshaw said suicide should be treated as a social issue as treating it as a medical issue actually increased suicide rates.



However, Hague said the Church of Scientology had a radical agenda against psychiatry and mental health services.



The CCHR website said it was co-founded in 1969 by the Church of Scientology and professor of psychiatry emeritus Dr Thomas Szasz.



Bradshaw said the CCHR had helped her and other families affected by suicide.



She was aware some members were scientologists, but she did not care about their religious views. "We don't feel that we have been captured, we are not scientologists, we just want people to have access to groups that provide counselling services."



Experts back NHS compensation moves - put the Fiddaman's out of business !!

Experts back NHS compensation moves


(UKPA) 2 days ago







http://www.google.com/hostednews/ukpress/article/ALeqM5iLRt2Xzqn-TdEM6CtTK3T4JNbZlQ?docId=N0054691298170783920A







A panel of independent experts has backed plans to reform the system of NHS compensation claims.



The No-Fault Compensation Review Group, headed by medical law and ethics professor Sheila McLean, was set up by ministers in 2009.



The body has recommended a change to the system which would mean patients who have suffered loss, injury or damage as a result of their treatment receive compensation without having to take the NHS to court.



The new arrangement would still require proof that harm was caused but would remove the need to prove negligence.



The review group's report suggests a no-fault system would allow for fair and adequate compensation while being speedier and more time- and cost-effective than the current one. A similar scheme is used in Sweden, New Zealand and several other countries.



The British Medical Association (BMA) welcomed the findings, saying no-fault compensation will end the "blame culture" within the NHS.



Scottish secretary Martin Woodrow said: "A system of no-fault compensation with maximum financial limits would benefit both doctors and patients, speeding up the process and reducing the legal expenses incurred by the current system. More importantly, however, it would address the blame culture within the NHS which discourages doctors from reporting accidents and would end the practice of defensive medicine."



Mr Woodrow said it was important that any new scheme did not significantly increase costs to the NHS and take money away from patient care.



Health Secretary Nicola Sturgeon said it was important that victims of medical mistakes have some form of redress but that it was in "no-one's best interests" to have to endure delays as the case goes through the courts or see taxpayers' money spent on expensive legal fees.



Ms Sturgeon said: "No-fault compensation would be a sensible way to ensure people who have been affected are compensated without tying up either patients or the health service in years of litigation. It's very encouraging that the review group's report has recommended this system."



Copyright © 2011 The Press Association. All rights reserved





Monday, 21 February 2011

Hal Ozsan & Fiddaman - and he want's a payout from GSK to take down his blog





The Evidence However is Clear ....Fiddaman was bought years ago

Fiddaman's award presented by Hal Ozsan - Hal Ozsan - Scientology Service Completions



source -

I've been hugged by a zillion people, chaperoned around Hollywood, been treated like a movie star because there's a bunch of people across the pond who can actually see   what I have been up against during my time writing this blog. Special thanks to the British actor, Hal Ozsan, who presented me with my award with a very touching introduction.


 
 
 
 
source - http://www.truthaboutscientology.com/stats/by-name/h/hal-ozsan.html
 

Toran Henry's scientology poodle mom fails to admit Prozac is approved for children in UK - source European Medicines Agency (EMEA)

Mrs Bradshaw disagrees: "I learned that the medication was not approved for people under the age of 18 some months after Toran's death and was absolutely shocked."




http://bobfiddaman.blogspot.com/2011/02/new-zealand-mom-just-another.html



In the United States the FDA require a "Black Box" warning to be displayed on all packets of fluoxetine. The warning explicitly states that "anti-depressants increased the risk compared to placebo of suicidal thinking and behaviour in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders"
 
=================================
 
Now check out the situation in UK & Europe and learn how Fiddaman only tells part of the story .......... yeah! the part that suits him.
 
source ©independent.co.uk
 
Prozac was considered to be the only drug that could be safe among children and the British government last year asked the makers, Eli Lilly, to submit an application to the EMEA for its use among under 18s.

The EMEA review of all the data concluded: "Overall, the benefits of Prozac are greater than its potential risks for the treatment of moderate to severe major depressive episode in children and adolescents."

It recommended that children start on a small dose of 10mg of Prozac a day, which could then be increased to 20mg after one or two weeks. Only patients who have not responded to at least four sessions of psychological therapy should be prescribed the drug and if no benefit is seen after nine weeks the treatment should be reconsidered.


New Zealand Mom - just another Scientology puppet - Maria Bradshaw mother of Toran Henry

Mrs Bradshaw continues her crusade. In November 2008 she is a guest speaker at an exhibition organised by the Citizens Commission on Human Rights (CCHR) founded by the Church of Scientology.

She tells the audience: "I've breached the Coroner's Act so many times I don't care. There is nothing I have to lose any more and nothing I won't do to have the truth told about my child."
 
 
 
 
 
Eighteen months after Toran Henry killed himself, his mother finally gets to have her say on whether an anti-depressant had an influence on his death. Chris Barton looks at the case that has raised questions about the drug's use



Toran Henry. Photo / Supplied





When Toran Tiavare Henry took his own life he was 17.



He left behind a grief-stricken mother, an absent father, devastated school friends and a string of questions.



The unfathomable why of it. Why one so young, so intelligent, with an active social life would take such a despairing, final step.



The question continues to haunt his mother and friends and even here, in the Auckland Coroner's Court, there is unlikely to be a satisfactory answer.



Inescapably with suicide, there are morbid questions of how? The method of death is explained to the court in matter-of-fact detail, but cannot be published because the Coroner's Act prohibits it - the rationale being such media reports may lead to copycat suicide attempts.



Talk is free, however, and Toran's friends, the staff and many students at Toran's school, Takapuna Grammar, all know how he did it and how he was found by his mother, Maria Bradshaw.



"There are no words to describe the shock of what I saw," his mother tells the court.



"It is a sight so shocking, so unnatural, that it is impossible for the brain to register what it is seeing."



Then there are questions about whether anything could have been done to stop such tragedy and who might be to blame. There are many "if only ... " possibilities.



His mother, in a frantic dash to get home to her son, arrives too late.



Several friends stop by just before he dies, but decide not to walk down the driveway to his house.



Teachers know Toran has been humiliated in a fight outside the school the day before his death, but no one contacts his mother.



A social worker, speaking by telephone to Toran just hours before he kills himself, notes an escalating situation: "He said that he was trying to reach out for help and his trust had been broken ... that this had been his last option and it hadn't worked out ... that he felt he had nowhere else to turn."



But the question that generates most debate in the inquest is what part, if any, his medication played in his death. Toran was taking Fluox, a generic form of the drug fluoxetine, better known as Prozac, for depression.



What's not commonly known about the drug is that it can have unwanted side effects, including suicidal thinking leading to suicide attempts. Could side effects have happened here?



The question is controversial. The consensus in New Zealand, and the advice from Medsafe, is there is "diminished but persisting increased risk of self-harm, hospitalisations, but not suicide, in patients prescribed a selective serotonin reuptake inhibitor (SSRI)" - the class of drugs which includes Prozac.



What can't be ignored, however, is special blood tests ordered after Toran's autopsy found fluoxetine at the low end of therapeutic levels. He also had a blood alcohol level of 148 milligrams per 100 millilitres.



Toran's mother is adamant Toran was caught in the grip of a medication induced "activation syndrome" - a cluster of symptoms including irritability, agitation, aggressiveness, impulsiveness and mood swings - that have been linked to an increased risk of suicide.



The health professionals involved in Toran's care are unconvinced - arguing that he didn't have side effects from the drug and other factors, such as depression, were more likely explanations for his death.



Expert witness Dr Sabina Dosani says the question of whether SSRIs are associated with an increase in suicidal events is still under debate in the academic and clinical psychiatric communities.



She refers to Dr David Healy, a professor in psychological medicine at Cardiff University who has published widely on the subject and who has for most of his career "held the view that fluoxetine (Prozac) and other SSRIs can lead to suicide".



Dr Dosani says the association between fluoxetine activation syndrome and suicide continues to be controversial. "No definitive conclusion yet exists. Against this backdrop, prescribing SSRI medication is standard practice and endorsed by the main regulatory and professional bodies."



Deborah Marshall, representing Waitemata District Health Board, asks Dr Dosani directly for her views.



Ms Marshall: Professor Healy has concluded that: "There is a compelling case that Prozac can trigger suicide in susceptible individuals." Would you agree with that statement?



Dr Dosani: I would not agree that there is a compelling case.



Ms Marshall: This next statement is: "There is little evidence that it is likely to be of benefit in patients in Toran Henry's age bracket." Would you agree with that?



Dr Dosani: No, I disagree with that.



Dr Healy, the author of more than 150 peer-reviewed articles and 20 books including Let Them Eat Prozac, and who has testified in 20 cases in which SSRI anti-depressants have been involved in cases of suicide or homicide, responds to Dr Dosani's evidence by a letter to the coroner.



He points to analysis of adult placebo controlled drug trials by the United States Food and Drug Administration (FDA) in 2006 which show a 2.3 fold increased rate of suicidal behaviours in people aged 18-24 years. Dr Healy refers also to drug trial data from Eli Lilly, the makers of Prozac.



"If we analyse the data as presented here it will be obvious to all members of the Court, even those without statistical or mathematical expertise, that the risk is significantly greater on Fluoxetine than on placebo. Infinitely greater."



By the time the inquest begins on November 9, some 19 months after his death on 20 March 2008, Toran's suicide has already been widely publicised in the press and on TV - primarily because Toran's mother speaks out.



Mrs Bradshaw ignores the Coroner's Act, which says no one can say a death is by suicide until the coroner says so. Even then, all that can normally be said is the name, address and occupation of the person and that the death was self-inflicted.



Media reports vary. Some are sensational. Some get the facts wrong. Some blatantly breach the act, announcing the death as suicide. Others use code words "tragic", "sudden" or "referred to the coroner".



Mrs Bradshaw doesn't stop speaking out. For several months after Toran's death, she is active on a website dedicated to her son.



Many of the posts on the site are outpourings of grief, but there is also detailed discussion about Toran's death and reactions from his friends.



The site serves also to organise a protest march up Queen St on May 13, 2008, the day Toran would have turned 18. In the face of a mother's grief, the Coroner's Act is impotent.



Mrs Bradshaw levels accusations at others involved in her son's care - Takapuna Grammar and the Marinoto North Child and Adolescent Mental Health Service of the Waitemata District Health Board.



The publicity appears to have some effect.



The school decides to conduct an independent inquiry headed by Sir Ian Barker. The Education Review Office investigates student safety at the school and Marinoto commissions an external review of Toran's engagement with the service.



Both the school and Marinoto make public the findings of their respective investigations.



Technically both have also breached the Coroner's Act, a point not lost on coroner Murray Jamieson: "I am confronted by some evidence that the Takapuna Grammar School and Waitemata District Health Board have engaged with the media in respect of matters which pertain to the proceedings before this court."



Mrs Bradshaw continues her crusade. In November 2008 she is a guest speaker at an exhibition organised by the Citizens Commission on Human Rights (CCHR) founded by the Church of Scientology.




She tells the audience: "I've breached the Coroner's Act so many times I don't care. There is nothing I have to lose any more and nothing I won't do to have the truth told about my child."



In March 2009, unhappy with results of the school's inquiry and still critical of Marinoto, Mrs Bradshaw releases her own report - Lessons Learned From The Death Of Toran Tiavare Henry - a 161-page, footnoted document with appendices.



Shortly after its release the coroner issues an order prohibiting making public any evidence or submissions about Toran's death. Even then, days before the inquest, he has to remind media organisations of the suppression order.



The reminder comes following postings on the Trade Me message board about the inquest and a news report in which Bradshaw confirms she wants to file a private manslaughter prosecution against a psychiatrist who treated Toran.



The coroner is not impressed: "The materials appear to contain statements or postings from an interested person in respect of the forthcoming inquest."



The net result of Mrs Bradshaw's actions is a swarm of lawyers - for the school, the Waitemata District Health Board, the police, plus two barristers representing two psychiatrists involved in Toran's care - bristling with evidence to counter her allegations.



The inquest, one of the longest on record, lasts 18 days.



Mrs Bradshaw is on the stand for four days, including two and a half days of robust cross examination. When her lawyer, Moira Macnab, raises concerns about the type of questioning the coroner points out it is happening, in part, because of suggestions by Mrs Bradshaw that she "intends to pursue individuals giving evidence at this inquest in venues other than this".



Senior Constable Paul Herman is the first to give evidence about the possible influence of fluoxetine. "Some of the friends would notice a difference when he was on the medication and then when he was not on the medication ... When he was on the medication it was a different type of behaviour that showed up." Mrs Bradshaw maintains her son suffered side effects including extreme fatigue and aggressiveness.



Those involved with his care point out there were other explanations for the tiredness, that it can also result from depression, and that Toran had exhibited aggressive and self-harming behaviour when he wasn't on medication.



Experts also point out that depression and anxiety can manifest as agitation and irritability in adolescents, as can substance abuse which, in Toran's case, mainly involved binge drinking. In the period of care leading up to his death, Marinoto staff maintain they were not told about Toran's increasing anger and aggression.



Medsafe group manager Dr Stewart Jessamine tells the court that because fluoxetine is not approved for major depressive disorder treatment in children and adolescents in New Zealand, the only way it can be given to that age group is by what's known as "off label" prescribing.



"This means informed consent must be obtained from the patient," he says.



Marinoto staff prescribing fluoxetine for Toran, in the two periods in 2007 and 2008 he was under their care, say informed consent was sought and, in the second instance, Toran asked to go back on the medication.



Both Toran and his mother were given information pamphlets which included information about side effects. Staff also say they discussed with Toran and his mother that the drug was not approved for those under 18 and that it carried a "Black Box" warning in the United States.



Mrs Bradshaw disagrees: "I learned that the medication was not approved for people under the age of 18 some months after Toran's death and was absolutely shocked."



In the United States the FDA require a "Black Box" warning to be displayed on all packets of fluoxetine. The warning explicitly states that "anti-depressants increased the risk compared to placebo of suicidal thinking and behaviour in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders".



The coroner asks Dr Jessamine why Medsafe doesn't require such a warning here. He says the Medicines Act doesn't allow for such a requirement and new legislation would be necessary to make it compulsory. Medsafe does, however, make consumer information about the drug available on its website.



After each expert witness testimony, the lawyer assisting the coroner asks three questions.



"Do you have any experience of suicidal thinking in such patients whilst you are treating them on fluoxetine?" All the experts say they have.



"Do you have any experience of suicide attempts in such patients?" Two of the experts say they have and one also has experience of a completed suicide.



"Can you give the coroner your view on how information about fluoxetine ought to be best provided to adolescent patients with depression and their parents, guardians and GPs?" Answers vary, but most indicate discussion followed by standardised written material would be desirable.



All experts also point out that while the drug can have side effects there is strong evidence that fluoxetine has benefits in the treatment of depression.



One of the psychiatrists who prescribed the drug for Toran is asked directly whether it was a mistake: "When prescribing fluoxetine to Toran I did not mean to harm him, which is part of our oath, and I prescribed him with my best intentions, as we prescribe to many other young people in New Zealand, and I do honestly not believe that by doing so I caused any harm to Toran whatsoever."



On the last day of the inquest the coroner makes an oral ruling: "On the evidence presented to me I am satisfied that the death was intentional and self-inflicted. No other persons were directly involved and I now adjourn this inquest for my written finding."

Sunday, 20 February 2011

Citizens Commission on Human Rights exposed as a Scientology front - Wikileaks

http://www.wikileaks.ch/wiki/Citizens_Commission_on_Human_Rights_exposed_as_a_Scientology_front


1. Download link just released into the chat forums at: http://forums.enturbulation.org/viewtopic.php?f=12&t=6059




2. The file contains e-mails between members of CCHR (an anti-psychiatry front group of the Church of Scientology)



3. Likely audience: anyone seeking psychological care for themselves or a loved one.



4. Visit the forum via the link above to join in the discussion of these leaked e-mails, and view the original post by the individual who leaked them. You may private message the individual there.



5. It was leaked for a number of reasons:



- Scientology denies that it is behind CCHR (which is clearly contradicted by the references in the emails)



- It shows, clearly, how Scientologists and the CCHR are deliberately manipulating the media... using false accounts and sock puppetry to skew information.



- It shows just how Machiavellian and hypocritical the CCHR is in their planning and execution of attacks against peer-reviewed medical science.



6. Yes. The CCHR's campaign of misinformation is designed specifically to derail people seeking psychiatric help, and instead funnel them toward Scientology. This nonsense, and lack of peer-reviewed treatment CCHR recommends instead (vitamins, niacin, hot saunas) is likely to harm rather than help.

Scientology warns Wikileaks over documents

Wikinews has learned that the Church of Scientology warned the documents-leaking site Wikileaks.org that they are in violation of United States copyright laws after they published several documents related to the Church. Wikileaks has no intention of complying, and states that in response, it intends to publish a thousand pages of additional Scientology materials beginning Monday.




In the letter to Wikileaks, lawyers for the Church's Religious Technology Center (RTC), which oversees the use of the their logos, writings and religious content, states that the site "placed RTC's Advanced Technology works on Wikileaks.org's website without the authorization" of the Church.



"I have a good faith belief, and in fact know for certain, that posting copies of these works through your system was not authorized by my client, any agent of my client, or the law. Please be advised that your customer's action in this regard violates United States copyright law. Accordingly, we ask for your help in removing these works immediately from your service," states the letter from Ava Paquette of Moxon & Kobrin, which was published by Wikileaks.



On March 9, 2008, Wikileaks published several documents relating to the Church's Office of Special Affairs and personal notes gathered by Frank Oliver, a former Scientologist and former member of the Church's Special Affairs office. On March 26, 2008, Wikileaks published the entire set of the Churches 'Operating Thetan Level' documents which included handwritten notes by Scientology's founder, L. Ron Hubbard.



Although the letter does not mention specific legal threats, the letter asks that Wikileaks "preserve any and all documents pertaining to this matter and this customer, including, but not limited to, logs, data entry sheets, applications -- electronic or otherwise, registration forms, billings statements or invoices, computer print-outs, disks, hard drives, etc."



Despite the letter, Wikileaks states it will not comply with the "abusive request" by the Church.



"Wikileaks will not comply with legally abusive requests from Scientology any more than Wikileaks has complied with similar demands from Swiss banks, Russian off-shore stem cell centers, former African Kleptocrats, or the Pentagon. Wikileaks will remain a place where people of the world may safely expose injustice and corruption," stated Wikileaks in a release on its website.



Wikileaks further states that, "in response to the attempted suppression, Wikileaks will release several thousand additional pages of Scientology material next week."



Scientology's LEAF Project - Letters To The Editor Attack Force - Exposed

Scientology's LEAF Project - Letters To The Editor Attack Force - Exposed


Every thing in Scientology is choreographed... a SHOW, an apparency,
designed to leave the uniformed public confused and to provide an
apparency of agreement that there is belief is a certain desired
fallacy that benefits the coffers of $cientology.









Teen Screen is legislation to interview school kids to prevent







SUICIDES...that is opoosed by the scam of scientology, because it is
based upon psychology and psychiatry...







I never had any doubt that all the letters to editors and the anti-
psych spam was coordinated, but you'll LOVE THIS:



"LEAF" = Letters to the Editor Attack Force



It was / is an actual group set up to do this...

Run by Doyle Mills, CW scientologist and OSA volunteer. He also works at Digital Light Wave



Note that in some of the letters he says: "report compliance by email"



So his "LEAF" operatives are commanded to report completion of
assignments back to him
 
Scientology's LEAF Project - Letters To The Editor Attack Force - post that won't go away


Scientology's LEAF Project - Letters To The Editor Attack Force - Exposed


http://groups.google.com/group/alt.religion.scientology/browse_thread/thread/944ee8cf50e0ee56/a661ab2134a23a9a
http

FIDDAMAN bought by a cult

http://fiddaman.blogspot.com/2011/02/2011-cchr-human-rights-awards-banquet.html#comments


comments:







Amy Philo said...






Right back atcha brother.


4:30 AM


Anonymous said...






You GO Fiddy! And all of us are right behind you carrying the flag of justice. Those bastards wont know what hit them! GlaxoSmithWHO? ForrestLabsWHO?...


Stop killing our babies damn you! STOP!


We're on to you and redemtion will not be pretty but it will be HAD! XoXo


4:59 AM


Chosen All said...






It's great you've been rewarded for your efforts and skills in the fight against the horrendous deceit and manipulation of big pharma.






I just wanted to add a caveat here that, as you will of course know, CCHR 'continues to be entirely controlled by and subject to policy directives issued from the Church of Scientology'.






They obscure this link in the UK by having separate websites for drawing in psychiatric abuse victims, which only includes a small link to CCHR, which only includes a small link to scientology. The latter's aim of course being, according to the current leader, "let's get rid of psychiatry, and let's bring Scientology to every man, woman and child on this planet"






I won't be surprised if my IP address now ends up on some list of Suppressive Persons.


10:14 AM


BOB FIDDAMAN [Fiddy] said...






Controlled by?






You really need to do your homework.






Can you tell me of another organisation other than CCHR that are banging the drum?






The anti-Scientology brigade, yourself included, need to step back and look at the bigger picture.






CCHR bring people together, I've known them for some time now, never have they forced anything on me.






Your thanks are appreciated but your rant misguided.


10:28 AM


Andrew John Younger said...






CCHR International gives all the global picture.






I'm for pro-choice helpful health care. "Chosen All" is that a private joke? When all only given one of is no choice to chose from Chosen All is a very unpopular monopoly at my house.






End chemical slavery.


11:41 AM


BOB FIDDAMAN [Fiddy] said...






Waste of time debating with these kind of folk Andrew. Critics rarely leave their real name as they cannot stand by their convictions.






Great to meet and talk with you.


11:48 AM


Anonymous said...






The controlled by comment was a quote from the Wikipedia article on CCHR... it's beyond doubt that it was set up by Scientology and is run by them, surely?






Chosen All is a random nickname chosen on the spot, lighten up.






If you're gonna insult people for commenting anonymously for their own protection, then maybe you should disable anonymous commenting. No one has any real idea if names that are given are real anyway.






I never said I was anti-scientology, I was simply pointing out well known links between them and CCHR that I'm sure you agree people should be aware of so they can make up their own mind. I am, of course, anti some of their techniques and stated goals. My main concern here is the possible undermining of credibility of anti-psych work in the eyes of many out there (who, granted, may not fully appreciate the extremity and extent of the harm being caused to people by mindless psych drugging).


1:30 PM


BOB FIDDAMAN [Fiddy] said...






Flourish and prosper and stop harping on about this. If you cannot grasp the message CCHR are relaying then go write a blog and include your thoughts.






End of debate


2:12 PM


Pharma Giles said...






Bob: Congratulations mate - thoroughly deserved after what you've been through. As we both know, there's nothing more than Big Pharma hates than being laughed at - it shows our contempt for them.






As for those trying to paint CCHR as some sort of front for the Church of Scientology, all I can say is that "scientologist" was one of the first insults the old DrugWonks blog used to reach for when someone said something it didn't like about their pet industry.






Looking forward to the book, you'll have to show me how to post an ad for it on the PG site.






All the best, Giles...


2:16 PM


BOB FIDDAMAN [Fiddy] said...






Thanks for the heads up on your blog Giles :-)






The AS Brigade don't bother me, it's quite laughable that their only tool is to use a label, ironic that the pharmaceutical industry and psychiatrists use this same labelling system to ply their wares into the mouths of children.






Thanks for your support


2:21 PM


christian said...






Wow... That's unfortunate that this beautiful piece turned into a debate over scientology.... I honor you for helping "Educate" people on the very real dangers that are creating havoc with in our world.... I had such a wonderful time getting to now who you are and I appreciate most sincerely your love for humanity... Much Love to you my valiant warrior!!!


2:36 PM


BOB FIDDAMAN [Fiddy] said...






Back atcha Christian. It was amazing being in your presence. You have a true gift my friend.


2:40 PM


Anonymous said...






I thought i'd grasped that one of the points of a blog with a comments facility, was for comments.






Congratulations on your work again anyway.


4:01 PM


Mark p.s.2 said...






Congratulations!


9:07 PM


Janne said...






Well done!


JanneL


11:51 PM


Anonymous said...






Absolutely and thoroughly well deserved fid. So good to see your great work recognized. Can't wait to here all about it. Sounds like an amazing event :)


5:12 AM


BOB FIDDAMAN [Fiddy] said...






Thank you Janne and anon :-)


1:21 PM


cynannetaylor said...






My only regret is that I didn't meet you at the event! You are a hero and keep up the incredible work you are doing. You have the best group behind you - CCHR!


Cynthia


8:23 PM


BOB FIDDAMAN [Fiddy] said...






Thank you Cynthia. You should have approached me.






You are correct - CCHR are rock n' roll